Learn more

DAKO AS

Overview
  • Total Patents
    65
About

DAKO AS has a total of 65 patent applications. Its first patent ever was published in 1986. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, measurement and pharmaceuticals are INTELLEXON GMBH, NEKONAL S A R L and CELL SIGNALING TECHNOLOGY INC.

Patent filings per year

Chart showing DAKO ASs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Pluzek Karl-Johan 21
#2 Stender Henrik 11
#3 Adelhorst Kim 8
#4 Hyldig-Nielsen Jens Joergen 8
#5 Lund Kaare 6
#6 Lohse Jesper 5
#7 Winther Lars 5
#8 Godskesen Michael Anders 5
#9 Hyldig-Nielsen Jens Jaergen 5
#10 Hyldig-Nielsen Jens Jorgen 4

Latest patents

Publication Filing date Title
US2003138866A1 Osp-C derived peptide fragments
US6458598B1 Process for preparing and presenting a tissue sample for histological study
EP1240520A2 Kit and method to assess the malignancy of neoplasias
US6930292B1 Method of controlling the temperature of a specimen in or on a solid support member
AU5522500A Benzoate buffers for zone electrophoresis and immunofixation
CA2376619A1 Detection using dendrimers bearing labels and probes
EP1078098A1 Method and probes for the detection of chromosome aberrations
EP0949508A1 Method, antigen complex and kit for diagnosing Lyme borreliosis
WO9934190A1 Cartridge device for processing a sample mounted on a surface of a support member
AU4549997A Novel probes for the detection of mycobacteria
US5888733A In situ hybridization to detect specific nucleic acid sequences in eucaryotic samples
AU6220096A Method for the simultaneous detection of different antibodies and/or antigens
AU4327296A Recombinant antibody capable of binding to pna/nucleic acid complexes
AU4327196A Monoclonal antibody capable of binding to pna/nucleic acid complexes
EP0760008A1 Pna probes for detection of neisseria gonorrhoeae and chlamydia trachomatis
FI940023A0 Water-soluble polymer-based reagents and conjugates containing divinyl sulfone-derived groups
DK145493D0 antibody
DK105491D0 Modified nucleosides and nucleotides and procedures for preparing them and using the same